Structure for family M27 unassigned peptidases
 
| TERTIARY STRUCTURE DATA | ||||||||
|---|---|---|---|---|---|---|---|---|
| Comment | Resolution | PDB | PDBe | SCOP | CATH | PDBSum | Proteopedia | Reference |
| Clostridium botulinum | ||||||||
| light chain only | 1.80 Å | 1E1H | 1E1H | 1E1H | 1E1H | 1E1H | 1E1H | Segelke et al., 2004 |
| mature peptidase | 1.80 Å | 1E1H | 1E1H | 1E1H | 1E1H | 1E1H | 1E1H | Segelke et al., 2004 |
| catalytic domain | 2.16 Å | 1T3A | 1T3A | 1T3A | 1T3A | 1T3A | 1T3A | Agarwal et al., 2004 |
| clostridium botulinum type e catalytic domain e212q mutant | 1.90 Å | 1T3C | 1T3C | 1T3C | 1T3C | 1T3C | 1T3C | Agarwal et al., 2004 |
| mature peptidase | 0.00 Å | 1UEE | 1UEE | 1UEE | 1UEE | 1UEE | 1UEE | |
| Glu224Gln, Tyr366Phe double mutant | 2.20 Å | 1XTF | 1XTF | 1XTF | 1XTF | 1XTF | 1XTF | Breidenbach & Brunger, 2004 |
| complex with synaptosomal-associated protein 25 | 2.10 Å | 1XTG | 1XTG | 1XTG | 1XTG | 1XTG | 1XTG | Breidenbach & Brunger, 2004 |
| Arg347Ala mutant; catalytic domain | 2.17 Å | 1ZKW | 1ZKW | 1ZKW | 1ZKW | 1ZKW | 1ZKW | Agarwal et al., 2005 |
| Glu158Ala/Thr159Ala/Asn160Ala triple mutant; catalytic domain | 2.52 Å | 1ZKX | 1ZKX | 1ZKX | 1ZKX | 1ZKX | 1ZKX | Agarwal et al., 2005 |
| Glu335Gln mutant; catalytic domain | 2.60 Å | 1ZL5 | 1ZL5 | 1ZL5 | 1ZL5 | 1ZL5 | 1ZL5 | Agarwal et al., 2005 |
| Tyr350Ala mutant; catalytic domain | 2.40 Å | 1ZL6 | 1ZL6 | 1ZL6 | 1ZL6 | 1ZL6 | 1ZL6 | Agarwal et al., 2005 |
| Glu335Ala mutant | 2.60 Å | 1ZN3 | 1ZN3 | 1ZN3 | 1ZN3 | 1ZN3 | 1ZN3 | Agarwal et al., 2005 |
| light chain | 2.00 Å | 2A8A | 2A8A | 2A8A | 2A8A | 2A8A | 2A8A | Agarwal et al., 2005 |
| catalytic domain | 1.80 Å | 2A97 | 2A97 | 2A97 | 2A97 | 2A97 | 2A97 | Agarwal et al., 2005 |
| light chain only | 1.65 Å | 2FPQ | 2FPQ | 2FPQ | 2FPQ | 2FPQ | 2FPQ | Arndt et al., 2006 |
| structure of the light chain of botulinum neurotoxin, serotype a bound to small molecule inhibitors | 2.80 Å | 2G7K | 2G7K | 2G7K | 2G7K | 2G7K | 2G7K | Fu et al., 2006 |
| structure of the light chain of botulinum neurotoxin serotype a bound to small molecule inhibitors | 1.90 Å | 2G7N | 2G7N | 2G7N | 2G7N | 2G7N | 2G7N | |
| structure of the light chain of botulinum neurotoxin serotype a bound to small molecule inhibitors | 2.30 Å | 2G7P | 2G7P | 2G7P | 2G7P | 2G7P | 2G7P | Fu et al., 2006 |
| structure of the light chain of botulinum neurotoxin serotype a bound to small molecule inhibitors | 2.41 Å | 2G7Q | 2G7Q | 2G7Q | 2G7Q | 2G7Q | 2G7Q | Fu et al., 2006 |
| clostridium botulinum serotype a light chain inhibited by 4- chlorocinnamic hydroxamate | 1.90 Å | 2ILP | 2ILP | 2ILP | 2ILP | 2ILP | 2ILP | Silvaggi et al., 2007 |
| clostridium botulinum neurotoxin serotype a light chain inhibited by 2,4-dichlorocinnamic hydroxamate | 1.94 Å | 2IMA | 2IMA | 2IMA | 2IMA | 2IMA | 2IMA | Silvaggi et al., 2007 |
| clostridium botulinum neurotoxin serotype a light chain inhibited by l-arginine hydroxamate | 2.41 Å | 2IMB | 2IMB | 2IMB | 2IMB | 2IMB | 2IMB | Silvaggi et al., 2007 |
| light chain only | 2.00 Å | 2IMC | 2IMC | 2IMC | 2IMC | 2IMC | 2IMC | Silvaggi et al., 2007 |
| light chain; crystal form A | 2.20 Å | 2ISE | 2ISE | 2ISE | 2ISE | 2ISE | 2ISE | Burnett et al., 2007 |
| light chain; crystal form B | 2.00 Å | 2ISG | 2ISG | 2ISG | 2ISG | 2ISG | 2ISG | Burnett et al., 2007 |
| light chain; crystal form c | 2.00 Å | 2ISH | 2ISH | 2ISH | 2ISH | 2ISH | 2ISH | Burnett et al., 2007 |
| complex with monoclonal antibody CR1 | 2.61 Å | 2NYY | 2NYY | 2NYY | 2NYY | 2NYY | 2NYY | Garcia-Rodriguez et al., 2007 |
| complex with monoclonal antibody AR2 | 3.79 Å | 2NZ9 | 2NZ9 | 2NZ9 | 2NZ9 | 2NZ9 | 2NZ9 | Garcia-Rodriguez et al., 2007 |
| structure of botulinum neurotoxin serotype c1 light chain protease | 1.75 Å | 2QN0 | 2QN0 | 2QN0 | 2QN0 | 2QN0 | 2QN0 | Jin et al., 2007 |
| mature peptidase | 1.60 Å | 2VU9 | 2VU9 | 2VU9 | 2VU9 | 2VU9 | 2VU9 | Stenmark et al., 2008 |
| mature peptidase | 1.70 Å | 2VUA | 2VUA | 2VUA | 2VUA | 2VUA | 2VUA | Stenmark et al., 2008 |
| mature peptidase | 2.59 Å | 2W2D | 2W2D | 2W2D | 2W2D | 2W2D | 2W2D | Masuyer et al., 2009 |
| apo-enzyme | 1.25 Å | 3BOK | 3BOK | 3BOK | 3BOK | 3BOK | 3BOK | Silvaggi et al., 2008 |
| with zinc bound | 1.20 Å | 3BON | 3BON | 3BON | 3BON | 3BON | 3BON | Silvaggi et al., 2008 |
| complex with inhibitory peptide | 1.40 Å | 3BOO | 3BOO | 3BOO | 3BOO | 3BOO | 3BOO | Silvaggi et al., 2008 |
| mature peptidase | 3.20 Å | 3BTA | 3BTA | 3BTA | 3BTA | 3BTA | 3BTA | Lacy et al., 1998 |
| mature peptidase | 1.70 Å | 3BWI | 3BWI | 3BWI | 3BWI | 3BWI | 3BWI | Kumaran et al., 2008 |
| catalytic domain from serotype A; complex with inhibitory peptide RRGC | 1.60 Å | 3C88 | 3C88 | 3C88 | 3C88 | 3C88 | 3C88 | |
| catalytic domain from serotype A; complex with inhibitory peptide RRGM | 1.58 Å | 3C89 | 3C89 | 3C89 | 3C89 | 3C89 | 3C89 | |
| mature peptidase | 1.52 Å | 3C8A | 3C8A | 3C8A | 3C8A | 3C8A | 3C8A | Kumaran et al., 2008 |
| mature peptidase | 1.47 Å | 3C8B | 3C8B | 3C8B | 3C8B | 3C8B | 3C8B | Kumaran et al., 2008 |
| mature peptidase | 1.50 Å | 3DDA | 3DDA | 3DDA | 3DDA | 3DDA | 3DDA | Kumaran et al., 2008 |
| mature peptidase | 1.60 Å | 3DDB | 3DDB | 3DDB | 3DDB | 3DDB | 3DDB | Kumaran et al., 2008 |
| type C; apo form (zinc removed) | 1.95 Å | 3DEB | 3DEB | 3DEB | 3DEB | 3DEB | 3DEB | |
| mature peptidase | 1.76 Å | 3DS9 | 3DS9 | 3DS9 | 3DS9 | 3DS9 | 3DS9 | Zuniga et al., 2008 |
| a potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than snap-25 substrate | 1.90 Å | 3DSE | 3DSE | 3DSE | 3DSE | 3DSE | 3DSE | |
| domain organization in clostridium butulinum neurotoxin type e is unique: its implication in faster translocation | 2.65 Å | 3FFZ | 3FFZ | 3FFZ | 3FFZ | 3FFZ | 3FFZ | Kumaran et al., 2009 |
| mature peptidase | 2.10 Å | 3FIE | 3FIE | 3FIE | 3FIE | 3FIE | 3FIE | Agarwal et al., 2009 |
| mature peptidase | 2.17 Å | 3FII | 3FII | 3FII | 3FII | 3FII | 3FII | Agarwal et al., 2009 |
| mature peptidase | 1.80 Å | 3FUO | 3FUO | 3FUO | 3FUO | 3FUO | 3FUO | Fu et al., 2009 |
| catalytic domain; complex with a llama antibody | 2.60 Å | 3K3Q | 3K3Q | 3K3Q | 3K3Q | 3K3Q | 3K3Q | |
| mature peptidase | 2.00 Å | 3N7J | 3N7J | 3N7J | 3N7J | 3N7J | 3N7J | Karalewitz et al., 2010 |
| mature peptidase | 2.50 Å | 3N7K | 3N7K | 3N7K | 3N7K | 3N7K | 3N7K | Karalewitz et al., 2010 |
| crystal structure of bont/a lc with jth-nb-7239 peptide | 2.40 Å | 3NF3 | 3NF3 | 3NF3 | 3NF3 | 3NF3 | 3NF3 | |
| mature peptidase | 1.72 Å | 3OBR | 3OBR | 3OBR | 3OBR | 3OBR | 3OBR | Strotmeier et al., 2010 |
| mature peptidase | 2.00 Å | 3OBT | 3OBT | 3OBT | 3OBT | 3OBT | 3OBT | Strotmeier et al., 2010 |
| mature peptidase | 1.65 Å | 3OGG | 3OGG | 3OGG | 3OGG | 3OGG | 3OGG | Zhang et al., 2010 |
| crystal structure of bont/a lc with zinc bound | 2.41 Å | 3QIX | 3QIX | 3QIX | 3QIX | 3QIX | 3QIX | |
| complex with hydroxamate-based inhibitor pt-1 | 2.30 Å | 3QIY | 3QIY | 3QIY | 3QIY | 3QIY | 3QIY | |
| complex with hydroxamate-based inhibitor pt-2 | 2.00 Å | 3QIZ | 3QIZ | 3QIZ | 3QIZ | 3QIZ | 3QIZ | |
| complex with hydroxamate-based inhibitor pt-3 | 2.30 Å | 3QJ0 | 3QJ0 | 3QJ0 | 3QJ0 | 3QJ0 | 3QJ0 | |
| crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rrgf | 1.60 Å | 3QW5 | 3QW5 | 3QW5 | 3QW5 | 3QW5 | 3QW5 | |
| crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rygc | 1.60 Å | 3QW6 | 3QW6 | 3QW6 | 3QW6 | 3QW6 | 3QW6 | |
| crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rrfc | 1.50 Å | 3QW7 | 3QW7 | 3QW7 | 3QW7 | 3QW7 | 3QW7 | |
| crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor crgc | 1.60 Å | 3QW8 | 3QW8 | 3QW8 | 3QW8 | 3QW8 | 3QW8 | |
| mature peptidase | 2.15 Å | 3R4S | 3R4S | 3R4S | 3R4S | 3R4S | 3R4S | Strotmeier et al., 2011 |
| mature peptidase | 2.20 Å | 3R4U | 3R4U | 3R4U | 3R4U | 3R4U | 3R4U | Strotmeier et al., 2011 |
| mature peptidase | 2.75 Å | 3RMX | 3RMX | 3RMX | 3RMX | 3RMX | 3RMX | Kroken et al., 2011 |
| mature peptidase | 2.30 Å | 3RMY | 3RMY | 3RMY | 3RMY | 3RMY | 3RMY | Kroken et al., 2011 |
| mature peptidase | 2.70 Å | 3V0A | 3V0A | 3V0A | 3V0A | 3V0A | 3V0A | Gu et al., 2012 |
| mature peptidase | 3.90 Å | 3V0B | 3V0B | 3V0B | 3V0B | 3V0B | 3V0B | Gu et al., 2012 |
| mature peptidase | 4.30 Å | 3V0C | 3V0C | 3V0C | 3V0C | 3V0C | 3V0C | Gu et al., 2012 |
| mature peptidase | 2.71 Å | 3ZUR | 3ZUR | 3ZUR | 3ZUR | 3ZUR | 3ZUR | Masuyer et al., 2011 |
| mature peptidase | 2.95 Å | 3ZUS | 3ZUS | 3ZUS | 3ZUS | 3ZUS | 3ZUS | Masuyer et al., 2011 |
| mature peptidase | 1.87 Å | 4EJ5 | 4EJ5 | 4EJ5 | 4EJ5 | 4EJ5 | 4EJ5 | Stura et al., 2012 |
| mature peptidase | 1.20 Å | 4EL4 | 4EL4 | 4EL4 | 4EL4 | 4EL4 | 4EL4 | Stura et al., 2012 |
| mature peptidase | 1.80 Å | 4ELC | 4ELC | 4ELC | 4ELC | 4ELC | 4ELC | Stura et al., 2012 |
| mature peptidase | 2.50 Å | 4HEV | 4HEV | 4HEV | 4HEV | 4HEV | 4HEV | Silhar et al., 2013 |
| mature peptidase | 2.30 Å | 4IQP | 4IQP | 4IQP | 4IQP | 4IQP | 4IQP | Przedpelski et al., 2013 |
| mature peptidase | 2.30 Å | 4JRA | 4JRA | 4JRA | 4JRA | 4JRA | 4JRA | Benoit et al., 2014 |
| crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 166-174 stretch | 1.93 Å | 4KS6 | 4KS6 | 4KS6 | 4KS6 | 4KS6 | 4KS6 | |
| crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 167-174 stretch | 2.59 Å | 4KTX | 4KTX | 4KTX | 4KTX | 4KTX | 4KTX | |
| crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134 mutant with mtsea modified cys-165 causing stretch disorder | 1.70 Å | 4KUF | 4KUF | 4KUF | 4KUF | 4KUF | 4KUF | |
| crystal structure of the catalytic domain of botulinum neurotoxin serotype a with a novel cyclic peptide inhibitor | 1.94 Å | 4ZJX | 4ZJX | 4ZJX | 4ZJX | 4ZJX | 4ZJX | |
| mature peptidase | 3.10 Å | 5BQM | 5BQM | 5BQM | 5BQM | 5BQM | 5BQM | Masuyer et al., 2015 |
| mature peptidase | 2.30 Å | 5BQN | 5BQN | 5BQN | 5BQN | 5BQN | 5BQN | Masuyer et al., 2015 |
| small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain | 2.50 Å | 5V8P | 5V8P | 5V8P | 5V8P | 5V8P | 5V8P | |
| small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain | 1.90 Å | 5V8R | 5V8R | 5V8R | 5V8R | 5V8R | 5V8R | |
| small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain | 2.05 Å | 5V8U | 5V8U | 5V8U | 5V8U | 5V8U | 5V8U | |
| structure of the c. botulinum neurotoxin serotype a with cu bound | 2.60 Å | 5VGV | 5VGV | 5VGV | 5VGV | 5VGV | 5VGV | |
| structure of the c. botulinum neurotoxin serotype a with hg bound | 2.15 Å | 5VGX | 5VGX | 5VGX | 5VGX | 5VGX | 5VGX | |
| Clostridium butyricum | ||||||||
| serotype E catalytic domain; complex with snap-25 substrate peptide | 2.25 Å | 3D3X | 3D3X | 3D3X | 3D3X | 3D3X | 3D3X | Agarwal & Swaminathan, 2008 |
